Trial Profile
Phase I/II trial of the tolerability and preliminary efficacy of a nanoparticulate formulation of doxorubicin in patients with liver cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2007
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Nov 2007 New trial record.